Published October 13, 2026 | Version XAII

raefalizadehnima-droid/Sustainable-Pathways-to-Trustworthy-AI-in-Pharmaceutical-Manufacturing: XAII

Authors/Creators

Description

The use of artificial intelligence (AI) is growing in pharmaceutical manufacturing, but regulatory assimilation has been slow due to difficulties in interpretability, uncertainty calibration and sustainability assessment. This work proposes a quantitative framework for assessing trustworthy AI through a multi-objective Composite Trust Index (CTI). The framework combines model predictive performance (R², RMSE), uncertainty measures (predictive variance and Expected Calibration Error), interpretability stability and sustainability metrics such as Process Mass Intensity (PMI), and is formulated for four AI paradigms: explainable AI (XAI), human-in-the-loop (HITL), hybrid physics-informed AI and uncertainty quantification (UQ).

Files

raefalizadehnima-droid/Sustainable-Pathways-to-Trustworthy-AI-in-Pharmaceutical-Manufacturing-XAII.zip

Additional details